Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian 361102, China.
Department of Cardiology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
J Chromatogr A. 2024 Jan 4;1713:464505. doi: 10.1016/j.chroma.2023.464505. Epub 2023 Nov 11.
Analysis of exposure to traditional Chinese medicine (TCM) in vivo based on mass spectrometry is helpful for the screening of effective ingredients of TCM and the development of new drugs. The method of screening biomarkers through metabolomics technology is a nontargeted research method to explore the differential components between two sets of biological samples. By taking this advantage, this study aims to takes Forsythia suspensa, which is a TCM also known as Lian Qiao (LQ), as the research object and to study its in vivo exposure by using metabolomics technology. By comparing the significant differences between biological samples before and after administration, it could be focused on the components that were significantly upregulated, where a complete set of analysis strategies for nontargeted TCM in vivo exposure mass spectrometry was established. Furthermore, the threshold parameters for peak extraction, parameter selection during statistical data analysis, and sample concentration multiples in this method have also been optimized. More interestingly, by using the established analysis strategy, we found 393 LQ-related chemical components in mice after administration, including 102 prototypes and 291 LQ-related metabolites, and plotted their metabolic profiles in vivo. In short, this study has obtained a complete mass spectrum of LQ exposure in mice in vivo for the first time, which provides a reference for research on the active ingredients of LQ in vivo. More importantly, compared with other methods, the analysis strategy of nontargeted exposure of TCM in vivo-based mass spectrometry, constructed by using this research method, has good universality and does not require self-developed postprocessing software. It is worth mentioning that, for the identification and characterization of trace amounts of metabolites in vivo, this analysis strategy has no discrimination and has a detection capability similar to that of highly exposed components.
基于质谱分析的中药体内暴露分析有助于筛选中药有效成分和开发新药。代谢组学技术筛选生物标志物的方法是一种非靶向研究方法,旨在探索两组生物样本之间的差异成分。利用这一优势,本研究以中药连翘(LQ)为研究对象,采用代谢组学技术研究其体内暴露情况。通过比较给药前后生物样本的显著差异,重点关注显著上调的成分,建立了一套完整的非靶向中药体内暴露质谱分析策略。此外,还优化了该方法中峰提取、统计数据分析过程中参数选择和样品浓度倍数等阈值参数。更有趣的是,通过使用建立的分析策略,我们在给药后的小鼠中发现了 393 种与 LQ 相关的化学成分,包括 102 种原型和 291 种 LQ 相关代谢物,并绘制了它们在体内的代谢图谱。总之,本研究首次获得了小鼠体内 LQ 暴露的完整质谱,为研究 LQ 体内活性成分提供了参考。更重要的是,与其他方法相比,本研究采用的研究方法构建的基于非靶向中药体内暴露质谱的分析策略具有良好的通用性,不需要自行开发后处理软件。值得一提的是,对于体内痕量代谢物的鉴定和表征,该分析策略没有歧视性,具有与高暴露成分相似的检测能力。